Free Trial
NASDAQ:IKNA

Ikena Oncology (IKNA) Stock Price, News & Analysis

Ikena Oncology logo
$1.40 +0.06 (+4.48%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Ikena Oncology Stock (NASDAQ:IKNA)

Key Stats

Today's Range
$1.32
$1.40
50-Day Range
$1.08
$1.47
52-Week Range
$0.97
$1.94
Volume
17,179 shs
Average Volume
115,164 shs
Market Capitalization
$67.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00
Consensus Rating
Moderate Buy

Company Overview

Ikena Oncology Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
61st Percentile Overall Score

IKNA MarketRank™: 

Ikena Oncology scored higher than 61% of companies evaluated by MarketBeat, and ranked 398th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Ikena Oncology has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Ikena Oncology has received no research coverage in the past 90 days.

  • Read more about Ikena Oncology's stock forecast and price target.
  • Earnings Growth

    Earnings for Ikena Oncology are expected to grow in the coming year, from ($0.91) to ($0.82) per share.

  • Price to Book Value per Share Ratio

    Ikena Oncology has a P/B Ratio of 0.53. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Ikena Oncology's valuation and earnings.
  • Percentage of Shares Shorted

    0.39% of the float of Ikena Oncology has been sold short.
  • Short Interest Ratio / Days to Cover

    Ikena Oncology has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Ikena Oncology has recently increased by 0.75%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Ikena Oncology does not currently pay a dividend.

  • Dividend Growth

    Ikena Oncology does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.39% of the float of Ikena Oncology has been sold short.
  • Short Interest Ratio / Days to Cover

    Ikena Oncology has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Ikena Oncology has recently increased by 0.75%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Ikena Oncology has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Ikena Oncology this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Ikena Oncology insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.94% of the stock of Ikena Oncology is held by insiders.

  • Percentage Held by Institutions

    75.00% of the stock of Ikena Oncology is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Ikena Oncology's insider trading history.
Receive IKNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ikena Oncology and its competitors with MarketBeat's FREE daily newsletter.

IKNA Stock News Headlines

Ikena Oncology (NASDAQ:IKNA) Shares Up 1.5% - Here's What Happened
Why Volatility Keeps Coming Back — And How I Trade It
Volatility isn’t the enemy — it’s the opportunity. While most traders panic during market swings, Jeff Clark uses a three-step method to target quick wins from VIX spikes and sudden price moves. It works in any market direction… and he’s showing how it works in a free video, available now.
William Blair Reaffirms Their Buy Rating on Ikena Oncology (IKNA)
See More Headlines

IKNA Stock Analysis - Frequently Asked Questions

Ikena Oncology's stock was trading at $1.64 on January 1st, 2025. Since then, IKNA shares have decreased by 15.2% and is now trading at $1.39.

Ikena Oncology, Inc. (NASDAQ:IKNA) announced its earnings results on Thursday, May, 8th. The company reported ($0.18) EPS for the quarter, topping analysts' consensus estimates of ($0.21) by $0.03.

Ikena Oncology (IKNA) raised $125 million in an IPO on Friday, March 26th 2021. The company issued 7,800,000 shares at $15.00-$17.00 per share. Jefferies, Cowen, Credit Suisse and William Blair served as the underwriters for the IPO.

Shares of IKNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ikena Oncology investors own include Waste Connections (WCN), iShares Micro-Cap ETF (IWC), The RMR Group (RMR), DiamondRock Hospitality (DRH), American Water Works (AWK), AU Optronics (AUOTY) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
5/08/2025
Today
7/10/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IKNA
CIK
1835579
Fax
N/A
Employees
70
Year Founded
N/A

Price Target and Rating

High Price Target
$4.00
Low Price Target
$2.00
Potential Upside/Downside
+115.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.86)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$49.23 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-30.59%
Return on Assets
-27.55%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
13.31
Quick Ratio
13.31

Sales & Book Value

Annual Sales
$9.16 million
Price / Sales
7.32
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.61 per share
Price / Book
0.53

Miscellaneous

Outstanding Shares
48,260,000
Free Float
45,391,000
Market Cap
$67.08 million
Optionable
Not Optionable
Beta
0.50
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:IKNA) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners